Avalyn Pharma Inc.(AVLN:US)
Market Cap$989.27M
Key Metrics
Price$23.66
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$92.31M
Total Assets$135.66M
Net Assets-$264.25M
Total Debt$16.41M
Key Metrics
Price$23.66
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$92.31M
Total Assets$135.66M
Net Assets-$264.25M
Total Debt$16.41M
Financials
| Name | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
Revenue | $0 | $0 |
Cost of Revenue | - | - |
Gross Profit | - | - |
| $27.91M | $18.72M | |
| Research and Development | $22.89M | $15.32M |
| Selling, General, and Administrative | $5.02M | $3.4M |
| Other Operating Expenses | - | - |
Operating Income | -$27.91M | -$18.72M |
| $1.04M | $1.21M | |
| Non-Operating Interest Income | $1.13M | $1.25M |
| Non-Operating Interest Expense | $98K | $0 |
| Other Income/Expense | $13K | -$35K |
Income Before Tax | -$26.87M | -$17.5M |
Income Tax | - | - |
Net Income | -$26.87M | -$17.5M |
Minority Interests | - | - |
Preferred Stock Dividends | - | - |
Net Income to Common | -$26.87M | -$17.5M |
Shares Outstanding (Basic) | 41.81M | 41.81M |
Shares Outstanding (Diluted) | 41.81M | 41.81M |
EPS (Basic) | -$0.64 | -$0.42 |
EPS (Diluted) | -$0.64 | -$0.42 |
EBIT | -$26.77M | -$17.5M |
EBITDA | -$26.71M | -$17.49M |